BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
McKinsey
Harvard Business School
Cerilliant
Merck
Deloitte
Accenture
McKesson
AstraZeneca
Express Scripts

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,248,735

« Back to Dashboard

Summary for Patent: 6,248,735
Title: Ophthalmic compositions comprising combinations of a carbonic anhydrase inhibitor and a .beta.-adrenergic antagonist
Abstract:Combinations of a .beta.-adrenergic antagonist and a topical carbonic anhydrase inhibitor are particularly useful in the treatment of ocular hypertension, especially in patients insufficiently responsive to treatment with .beta.-adrenergic antagonists.
Inventor(s): Baldwin; John J. (Gwynedd Valley, PA)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:08/833,067
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Compound; Dosage form;

Drugs Protected by US Patent 6,248,735

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 6,248,735

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 1066781 ➤ Subscribe
China 1073421 ➤ Subscribe
Cyprus 2146 ➤ Subscribe
Czech Republic 9302098 ➤ Subscribe
Czech Republic 285129 ➤ Subscribe
Germany 10075002 ➤ Subscribe
Germany 69229688 ➤ Subscribe
Denmark 0509752 ➤ Subscribe
European Patent Office 0509752 ➤ Subscribe CA 2000 00002 Denmark ➤ Subscribe
European Patent Office 0509752 ➤ Subscribe C990041 Netherlands ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Boehringer Ingelheim
Harvard Business School
Merck
Moodys
Healthtrust
Mallinckrodt
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot